{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib", "item": "https://www.patentleaderboard.com/patent/9375443"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib

US Patent 9375443 · Granted Jun 28, 2016

Estimated economic value: $499,474,000

Assignee

Inventors

View full patent text on Google Patents →